載入...
Asymmetrical dimethylarginine: A novel risk factor for coronary artery disease
Background: Asymmetrical dimethylarginine (ADMA) is an endogenous competitive inhibitor of nitric oxide synthase and has been associated with systemic atherosclerosis; however, the role of ADMA in patients with coronary artery disease (CAD) has not been investigated. Hypothesis: The present study wa...
Na minha lista:
| 發表在: | Clin Cardiol |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Wiley Periodicals, Inc.
2006
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6654648/ https://ncbi.nlm.nih.gov/pubmed/14579916 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.4960261006 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|